Panagiota Georgiadou
Overview
Explore the profile of Panagiota Georgiadou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonios M, Miliopoulos D, Gkouziouta A, Kogerakis N, Fragkoulis S, Armenis I, et al.
Hellenic J Cardiol
. 2024 Oct;
PMID: 39427760
Objective: In patients with advanced heart failure, heart transplantation is currently the most effective treatment. However, in a low-organ donation environment, it is usually necessary to proceed in long-term mechanical...
2.
Georgiadou P, Sbarouni E, Elefteriades J
Front Cardiovasc Med
. 2024 Aug;
11:1457521.
PMID: 39087070
No abstract available.
3.
Zymatoura M, Georgiadou P, Perlepe K, Tsiapras D, Katsilouli S, Voudris V, et al.
J Cardiol Cases
. 2023 Apr;
27(4):184-187.
PMID: 37012919
Learning Objective: Caseous calcification of the mitral annulus is a rare form of mitral annular calcification which is associated with high risk of strokes.Medical management with optimal anticoagulation can be...
4.
Bonios M, Armenis I, Kogerakis N, Thodou A, Fragoulis S, Georgiadou P, et al.
ASAIO J
. 2023 Mar;
69(6):e215-e222.
PMID: 37000672
Intra-aortic balloon pump (IABP) may be applied to optimize advanced heart failure (AHF) patients and improve right ventricular (RV) function before left ventricular assist device (LVAD) implantation. We aimed to...
5.
Mete B, Pekbilir E, Bilge B, Georgiadou P, Celik E, Sutlu T, et al.
Life Sci Alliance
. 2022 Feb;
5(6).
PMID: 35181598
During infection, the human immunodeficiency virus type 1 (HIV-1) manipulates host cell mechanisms to its advantage, thereby controlling its replication or latency, and evading immune responses. Sumoylation is an essential...
6.
Ergunay T, Ayhan O, Celen A, Georgiadou P, Pekbilir E, Abaci Y, et al.
Life Sci Alliance
. 2022 Jan;
5(4).
PMID: 35022246
CRISPR/Cas9 is a popular genome editing technology. Although widely used, little is known about how this prokaryotic system behaves in humans. An unwanted consequence of eukaryotic Cas9 expression is off-target...
7.
Sbarouni E, Georgiadou P, Manavi M, Analitis A, Beletsioti C, Niakas D, et al.
Hellenic J Cardiol
. 2021 Feb;
62(6):463-465.
PMID: 33524616
No abstract available.
8.
Kontonika M, Armenis I, Georgiadou P, Mastorakou I, Voudris V, Katsilouli S
J Cardiovasc Comput Tomogr
. 2019 Oct;
14(6):e125-e127.
PMID: 31585839
No abstract available.
9.
Voudris V, Georgiadou P, Kalogris P, Kostelidou T, Karabinis A, Gerotziafas G
Am J Case Rep
. 2019 May;
20:753-757.
PMID: 31133634
BACKGROUND Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy, characterized by thrombocytopenia and high risk for venous and arterial thrombosis. CASE REPORT We report an unusual case of...
10.
Sbarouni E, Georgiadou P
J Thorac Dis
. 2018 May;
10(3):1256-1257.
PMID: 29708184
No abstract available.